Skip to main content

Year: 2019

PLUS Products Announces Date for the Release of Third Quarter 2019 Results, Conference Call and Webcast

SAN MATEO, Calif., Nov. 25, 2019 (GLOBE NEWSWIRE) — Plus Products Inc. (CSE: PLUS) (OTCQX: PLPRF) (the “Company” or “PLUS”) today announced it will release its financial results for the third quarter ended September 30, 2019 after market closes on Friday, November 29, 2019.Conference Call DetailsThe following business day, Monday, December 2, 2019 at 8:30am Eastern Time / 5:30am Pacific Time, the Company will host a conference call and webcast to discuss the financial results and its recent corporate highlights.Participant Dial-In Numbers:Toll-Free:  1-877-407-0784Toll / International:  1-201-689-8560*Participants should request the Plus Products Earnings Call or provide confirmation code 13696648The call will be webcast on the Plus Products Investor page of the Company website at https://www.plusproductsinc.com. Please visit the...

Continue reading

Neuronetics to Present at the 31st Annual Piper Jaffray Healthcare Conference

MALVERN, Pa., Nov. 25, 2019 (GLOBE NEWSWIRE) — Neuronetics, Inc. (NASDAQ:STIM), a commercial stage medical technology company focused on designing, developing and marketing products that improve the quality of life for patients who suffer from psychiatric disorders, today announced that Chris Thatcher, President and Chief Executive Officer, and Steve Furlong, Chief Financial Officer, will participate in the 31st Annual Piper Jaffray Healthcare Conference in New York, NY on Thursday, December 5, 2019. The Company is scheduled to present at the conference at 2:00 PM Eastern Time the same day.A live audio webcast of the conference presentation will be available online at the investor relations page of the Company’s website at ir.neuronetics.com. A replay of the webcast will be archived on the website for approximately 90 days.About...

Continue reading

BrainsWay Reports Third Quarter 2019 Financial Results and Operational Highlights

JERUSALEM, Israel and HACKENSACK, N.J., Nov. 25, 2019 (GLOBE NEWSWIRE) — BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in the advanced non-invasive treatment of brain disorders, today reported financial results for the quarter ended September 30, 2019, and provided an operational update.“We are pleased with our solid performance in the third quarter of this year,” said Dr. David Zacut, Chairman, Interim CEO and a founder of BrainsWay. “These positive results reflect the continued increase in demand for our Deep Transcranial Magnetic Stimulation system (Deep TMS) and the sustained momentum of our business during the Company’s strategic transition to U.S.-based leadership, which began during the third quarter with the relocation of our Chief Financial Officer and Chief Operations Officer,...

Continue reading

GQ Executes Definitive Agreement to Acquire 1184700 BC Ltd.

VANCOUVER, British Columbia, Nov. 25, 2019 (GLOBE NEWSWIRE) — Great Quest Fertilizer Ltd (TSXV:GQ) (the “Company”) is pleased to announce, further to its press releases of September 13, 2018 and December 18, 2018, that it has now entered into non-arm’s length binding agreement (the “Definitive Agreement”) pursuant to which it will acquire all of the issued and outstanding shares of 1184700 BC Ltd. (“Privco”) (the “COB Transaction”). Privco is a private company incorporated in British Columbia and is the beneficial shareholder of 80% of the issued shares of Ivoirienne de Noix de Cajou SA (INCAJOU). The remaining 20% is owned by an arm’s length local partner. Upon the completion of the COB Transaction, the Company will continue the business of INCAJOU. The COB Transaction will constitute a “Change of Business” transaction pursuant...

Continue reading

GBT’s Communication Microchip Patent Received Final Allowance Notice

SANTA MONICA, Calif., Nov. 25, 2019 (GLOBE NEWSWIRE) — GBT Technologies Inc. (OTC PINK: GTCH) (“GBT”, or the “Company”), a company specializing in the development of Internet of Things (IoT) and Artificial Intelligence (AI) enabled networking and tracking technologies, including its GopherInsight™ wireless mesh network technology platform and its Avant! AI, for both mobile and fixed solutions, announced that its communication microchip patent application received final allowance notice and expected to be granted during the first quarter of 2020.GBT’s patent application for its secured communication integrated microchip (“IC”), named GopherInsight™, protects innovative integrated circuit technology targeted to be installed on IoT/mobile devices.The microchip is designed to create a private, secured network for sharing...

Continue reading

Debtor distribution data – Nykredit Realkredit A/S

To the Nasdaq Copenhagen25 November 2019   Debtor distribution dataPursuant to s 24 Danish Capital Markets Act, Nykredit Realkredit A/S hereby publishes debtor distribution data for callable mortgage bond series as at 22 November 2019 in the attached file.Furthermore, the data will be distributed in the usual way through Nasdaq Copenhagen. Data on Nykredit and Totalkredit bonds is also available by ISIN code in Excel format on https://www.nykredit.com/filarkiv/.For further information about data format and contents, please refer to the Nasdaq website.Questions may be addressed to Morten Bækmand Nielsen, Head of Investor Relations, tel +45 44 55 15 21.Yours sincerelyNykredit Realkredit A/SAttachmentsDebtor distribution data – Nykredit Realkredit – 25112019debisams – 25112019

Continue reading

Debtor distribution data – Totalkredit A/S

To the Nasdaq Copenhagen25 November 2019Debtor distribution dataPursuant to s 24 Danish Capital Markets Act, Totalkredit A/S hereby publishes debtor distribution data for callable mortgage bond series as at 22 November 2019 in the attached file.Furthermore, the data will be distributed in the usual way through Nasdaq Copenhagen. Data on Nykredit and Totalkredit bonds is also available by ISIN code in Excel format on https://www.nykredit.com/filarkiv/.For further information about data format and contents, please refer to the Nasdaq website.Questions may be addressed to Morten Bækmand Nielsen, Head of Investor Relations, tel +45 44 55 15 21.Yours sincerelyTotalkredit A/SAttachmentsDebtor distribution data – Totalkredit – 25112019debisamstk – 25112019

Continue reading

Emerging Markets Report: Follow the Leader

ORLANDO, Fla., Nov. 25, 2019 (GLOBE NEWSWIRE) — The Life Science industry is perhaps one of the most exciting industries represented in the stock market. Not only are the market sectors often massive and rife with revenue potential, the products and services in Life Science deals can truly be life changing. New medicines, cures, treatments- a vast and beneficial gamut of ways to make life better.But there is an inherent problem for many emerging medical technology companies as they endeavor down the winding path of development, government approvals and monetization. The problem, simply put, is that the deals are often so technical that the average investor just can’t understand where they are in their progression and pursuit of the market opportunity.But sometimes, just sometimes, you get an opportunity to follow the leader. In...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.